1 July 2026
Sulnox Group Plc
(the "Company" or "Sulnox")
Update on Admission,
Total Voting Rights and
Holdings in the Company
(Aquis Stock Exchange: SNOX, OTCQX: SNOXF)
Sulnox, the greentech company delivering lower fuel costs and emissions with zero capex, provides an update on the admission of the 7,058,200 new ordinary shares of 2 pence each ("Ordinary Shares") to be issued to EPS Ventures Pte Ltd, which was announced on 22 June 2026. An application for admission to trading on the Aquis Growth Market has been made, with admission effective on 6 July 2026.
On Admission, the Company will have 151,608,359 Ordinary Shares in issue, each with one voting right. The Company does not hold any shares in treasury and therefore the total number of voting rights in the Company is 151,608,359. This figure should be used by shareholders from Admission as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
On Admission, the significant shareholdings, to the best of the knowledge of the Company, will be as follows:
Shareholder Current Ordinary Shares Held % of Current Ordinary Shares Held | Constantine Logothetis * 37,726,548 24.88% | Nistadgruppen AS 19,484,663 12.85% | EPS Ventures Pte Ltd 16,411,820 10.83% | James Redman Jr. 8,659,200 5.71% | Richard Leggatt 6,807,500 4.49% | Unicorn Asset Management 6,264,779 4.13% | Artemar Inc. 5,476,888 3.61% |
* This includes shares held by Tergeo Ltd, Arrowcove Ltd and Kambos SA in which Constantine Logothetis holds a majority interest.
ENDS
For further information please contact:
Sulnox Group plc Alex Judd, Head of Marketing & Communications alex.judd@sulnoxgroup.com | Allenby Capital Limited (Aquis Corporate Adviser) Nick Harriss / John Depasquale (Corporate Finance) Amrit Nahal (Equity Sales) Tel: 020 3328 5656 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END NEXRBMATMTAMMTF